SGRY Surgery Partners, Inc.
Healthcare$13.40+0.87%ClosedMarket Cap: $1.75B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$19.25
Target (Median)
$19.50
Target Range
$17.00 - $21.00
Upside from current price: 43.7%
Rating Distribution
1 Strong Buy8 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-05 | TD Cowen | maintain | Buy | Buy |
| 2026-03-05 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-05 | UBS | maintain | Buy | Buy |
| 2026-03-04 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-03 | Barclays | maintain | Equal Weight | Equal Weight |
| 2025-12-18 | Mizuho | maintain | Outperform | Outperform |
| 2025-11-24 | JP Morgan | maintain | Neutral | Neutral |
| 2025-11-21 | Barclays | maintain | Equal Weight | Equal Weight |
| 2025-11-17 | Mizuho | maintain | Outperform | Outperform |
| 2025-11-13 | UBS | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $0.41 | $3.41B | 7 |
| Fri Dec 31 | $0.62 | $3.59B | 7 |
| Sun Dec 31 | $0.84 | $3.81B | 3 |
| Mon Dec 31 | $1.18 | $4.46B | 1 |